Trial intelligence / Profile preview

Patient-controlled propofol sedation without opioids in gynecological outpatient surgery

2016-001373-33Phase 4Active

Sponsor
Region Östergötland
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol, sponsored by Region Östergötland. Primary endpoint: Risk of depressed respiration with different propofol doses. Started Aug 2016; status: active.

02

Drugs

propofol

Beyond the preview

Go deeper on 2016-001373-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001373-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call